Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience
- 30 June 2020
- journal article
- research article
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 22 (2) , 261-265
Abstract
Relapsing peritonitis due to the development of a biofilm in the catheter’s lumen remains an important complication of peritoneal dialysis therapy that endangers technique continuity. Taurolidine catheter lock has proven efficient reducing infection rates in permanent hemodialysis catheters based on its biocidal activity and biofilm detachment effect. Efficacy evidence on its use in peritoneal dialysis catheters is lacking. We retrospectively analyzed all relapsing peritonitis episodes from June 2018 until October 2019 in our center. Patients were identified and data were collected from our electronic renal registry and patient’s records. Six patients were identified during the study period. Most patients (66.6%) were on automated peritoneal dialysis and the median duration of peritoneal dialysis before the episode of taurolidine was started was 43.66 ± 29.64 months. Mean taurolidine doses were 10 (range: 9–11) and 83.3% (five patients, with peritonitis caused by Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, and Corynebacterium propinquum) had a favorable response and microbial eradication without relapses after taurolidine treatment. Only one patient relapsed by the same organism (Corynebacterium amycolatum) due to non-adherence to the antibiotic treatment prescribed. None of the patients experienced any relevant adverse events, with only two out of six presenting mild transient abdominal discomfort. We believe that peritoneal catheter taurolidine lock could be considered in cases of relapsing or refractory peritonitis, as it could prevent catheter removal and permanent switch to hemodialysis in selected cases, although literature is scarce and further studies are needed.Keywords
This publication has 14 references indexed in Scilit:
- ISPD Peritonitis Recommendations: 2016 Update on Prevention and TreatmentPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2016
- Evidence-Based Criteria for the Choice and the Clinical use of the Most Appropriate Lock Solutions for Central Venous Catheters (Excluding Dialysis Catheters): A GAVeCeLT ConsensusThe Journal of Vascular Access, 2016
- Diálisis peritoneal automática adaptada: un método de prescripción eficaz, eficiente y seguroEnfermería Nefrológica, 2014
- Peritoneal Dialysis–Related Peritonitis: Towards Improving Evidence, Practices, and OutcomesAmerican Journal of Kidney Diseases, 2014
- Peritoneal dialysis associated infections: An update on diagnosis and managementWorld Journal of Nephrology, 2012
- Infectious complications in dialysis—epidemiology and outcomesNature Reviews Nephrology, 2011
- Prevention of infectious complications in peritoneal dialysis: best demonstrated practicesKidney International, 2006
- Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solutionNephrology Dialysis Transplantation, 2004
- Antimicrobial Activity of a Novel Catheter Lock SolutionAntimicrobial Agents and Chemotherapy, 2002
- Successful Use of Recombinant Tissue Plasminogen Activator in a Patient With Relapsing PeritonitisAmerican Journal of Kidney Diseases, 2001